12(S)-hydroxyeicosatrienoic acid (12(S)-HETrE) compounds and compositions comprising the same are disclosed. Methods of using the compounds in the prevention and treatment of thrombosis and thrombotic disorders are also disclosed.

Disclosed are an ionic liquid, having wear resistance maintained at low temperatures and containing a divalent cation including at least one of bis(ammonium) and bis(phosphonium) and a monovalent anion including at least one of sulfonate and phosphate, and a lubricant composition including the ionic liquid.

Disclosed are an ionic liquid, having wear resistance maintained at low temperatures and containing a divalent cation including at least one of bis(ammonium) and bis(phosphonium) and a monovalent anion including at least one of sulfonate and phosphate, and a lubricant composition including the ionic liquid.

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

A binder composition for nonaqueous battery electrodes essentially contains (A) an ethylenically unsaturated monomer and (B) a surfactant, and further satisfies any two or more conditions of the following (I) to (III): (I) (A) the ethylenically unsaturated monomer includes (a) a phosphoric acid group-containing ethylenically unsaturated monomer; (II) (B) the surfactant comprises (b) a phosphoric acid group-containing surfactant; and (III) the composition including (C) a neutralizing agent containing an alkali metal compound and/or an alkali earth metal compound.

A binder composition for nonaqueous battery electrodes essentially contains (A) an ethylenically unsaturated monomer and (B) a surfactant, and further satisfies any two or more conditions of the following (I) to (III): (I) (A) the ethylenically unsaturated monomer includes (a) a phosphoric acid group-containing ethylenically unsaturated monomer; (II) (B) the surfactant comprises (b) a phosphoric acid group-containing surfactant; and (III) the composition including (C) a neutralizing agent containing an alkali metal compound and/or an alkali earth metal compound.

Disclosed are an ionic liquid, having wear resistance maintained at low temperatures and containing a divalent cation including at least one of bis(ammonium) and bis(phosphonium) and a monovalent anion including at least one of sulfonate and phosphate, and a lubricant composition including the ionic liquid.

Disclosed are an ionic liquid, having wear resistance maintained at low temperatures and containing a divalent cation including at least one of bis(ammonium) and bis(phosphonium) and a monovalent anion including at least one of sulfonate and phosphate, and a lubricant composition including the ionic liquid.

Disclosed are a near-infrared absorbing composition including a copper complex represented by Chemical Formula 1, a near-infrared absorption layer formed by using the near-infrared absorbing composition including the copper complex represented by Chemical Formula 1, an optical structure including the near-infrared absorption layer, and a camera module or an electronic device including the optical structure, wherein Chemical Formula 1 is provided below, and ##STR00001##
and in Chemical Formula 1, R.sup.1, R.sup.2, x, and y are the same as described in the detailed description.